chondromalacia patellae
Recently Published Documents


TOTAL DOCUMENTS

141
(FIVE YEARS 3)

H-INDEX

30
(FIVE YEARS 0)

2021 ◽  
Vol 7 (10) ◽  
Author(s):  
Thiago Fernandes Peixoto Silva ◽  
Gabriel Henrique Resende Melo ◽  
Alexandre Pereira Da Silva Filho ◽  
Carolina Albernaz Henriques ◽  
Fernando Tostes Peixoto ◽  
...  


2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Weitao Zheng ◽  
Hanluo Li ◽  
Kanghong Hu ◽  
Liming Li ◽  
Mingjian Bei

AbstractChondromalacia patellae (CMP), also known as runner’s knee, typically occurs in young patients, which is characterized by anterior knee pain (AKP) that is associated with visible changes in patellar cartilage. The initial pathological changes include cartilage softening, swelling, and edema. CMP is caused by several factors, including trauma, increased cartilage vulnerability, patellofemoral instability, bony anatomic variations, abnormal patellar kinematics, and occupation hazards. CMP may be reversible or may progress to develop patellofemoral osteoarthritis. Quadriceps wasting, patellofemoral crepitus, and effusion are obvious clinical indications. Additionally, radiological examinations are also necessary for diagnosis. Magnetic resonance imaging (MRI) is a non-invasive diagnostic method, which holds a promise in having the unique ability to potentially identify cartilage lesions. Modalities are conventionally proposed to treat cartilage lesions in the PF joint, but none have emerged as a gold standard, neither to alleviated symptoms and function nor to prevent OA degeneration. Recently, researchers have been focused on cartilage-targeted therapy. Various efforts including cell therapy and tissue emerge for cartilage regeneration exhibit as the promising regime, especially in the application of mesenchymal stem cells (MSCs). Intra-articular injections of variously sourced MSC are found safe and beneficial for treating CMP with improved clinical parameters, less invasiveness, symptomatic relief, and reduced inflammation. The mechanism of MSC injection remains further clinical investigation and is tremendously promising for CMP treatment. In this short review, etiology, MRI diagnosis, and treatment in CMP, especially the treatment of the cell-based therapies, are reviewed.



2020 ◽  
Vol 54 (2) ◽  
pp. 159-167
Author(s):  
Mohammadreza Tabary ◽  
Azadehsadat Esfahani ◽  
Mehdi Nouraie ◽  
Mohammad Reza Babaei ◽  
Ali Reza Khoshdel ◽  
...  

AbstractBackgroundMagnetic resonance imaging (MRI) is a non-invasive highly sensitive tool for diagnosing chondromalacia patellae in the early stages. Many studies have evaluated patellar and trochlear morphology with different radiologic indices. We aimed to assess the discriminative power of tibial, patellar, and femoral indices in MRI for chondromalacia patellae.Patients and methods100 cases of chondromalacia, as well as 100 age-matched controls among the patients who underwent knee MRI between February 2017 and March 2019, were included. The standard protocol of knee MRI was applied and the diagnosis of chondromalacia was made on MRI findings. Chondromalacia subjects were also classified as grade 1 to 4 according to the Modified Outerbridge’s MRI grading system. We measured 25 MRI parameters in the knee and adjacent structures to determine the relation between chondromalacia patellae and anatomical MRI parameters.ResultsTibial slope, trochlear depth, lateral trochlear inclination, and lateral patellar tilt angle had significant correlation with chondromalacia. Any increase in lateral trochlear inclination and lateral patellar tilt angle could increase the probability of the disease (Odds ratio [OR] 1.15, 1.13; 95% CI: 1.03–1.30; 1.02–1.26, respectively), while any increase in medial tibial slope and trochlear depth could decrease the probability of chondromalacia (OR 0.85, 0.06; 95% CI: 0.73–0.98, 0.02–0.17, respectively). We also designed a model for the severity of disease by using the patellar height index (relative odds ratio: 75.9).ConclusionsThe result of this study showed the novelty role of tibial anatomy in developing chondromalacia and its mechanism. We also concluded that patellar height might be an important factor in defining disease severity.





Up to 40% of all athletes suffer from patellofemoral disorders every season, with a high prevalence of 15-25% especially in pivoting sports [1]. It has a high risk of recurrence, might persist for a prolonged time and therefore considerably influence the athlete’s trainability and performance over his career. Exercise-related, peripatellar pain is the most frequent observed condition and usually described as anterior knee pain (AKP), or synonymously called patellofemoral pain syndrome (PFPS). The formerly used term “chondromalacia patellae” has been shown to be misleading, and is no longer used in literature...



2020 ◽  
Vol 30 (4) ◽  
pp. 312-316
Author(s):  
艳娜 朱 ◽  
玉鹏 柳 ◽  
小艺 范 ◽  
春玲 刘 ◽  
慧 于 ◽  
...  


2019 ◽  
Vol 12 (1) ◽  
pp. 412
Author(s):  
A. Vijayalakshmi ◽  
S. Sangeetha ◽  
N. Ranjith


2018 ◽  
Vol 50 (1) ◽  
pp. 28-33 ◽  
Author(s):  
Idil Kurut Aysin ◽  
Ayhan Askin ◽  
Berna Dirim Mete ◽  
Ece Guvendi ◽  
Murat Aysin ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document